Skip to Main Content

Author Details

Arul M Chinnaiyan
University of Michigan Medical School.
1993
619
148
PMIDPaper TitleJournal TitlePublished Year
36097168Prospective comparison of restriction spectrum imaging and non-invasive biomarkers to predict upgrading on active surveillance prostate biopsy.Prostate Cancer Prostatic Dis2024
36097168Prospective comparison of restriction spectrum imaging and non-invasive biomarkers to predict upgrading on active surveillance prostate biopsy.Prostate Cancer Prostatic Dis2024
37994665Hybrid Oncocytic Tumors (HOTs) in Birt-Hogg-Dubé Syndrome Patients-A Tale of Two Cities: Sequencing Analysis Reveals Dual Lineage Markers Capturing the 2 Cellular Populations of HOT.Am J Surg Pathol2024
38079361Reply to "Contextualizing racial associations in prostate cancer to expose structural causes".Cancer2024
38079361Reply to "Contextualizing racial associations in prostate cancer to expose structural causes".Cancer2024
37994665Hybrid Oncocytic Tumors (HOTs) in Birt-Hogg-Dubé Syndrome Patients-A Tale of Two Cities: Sequencing Analysis Reveals Dual Lineage Markers Capturing the 2 Cellular Populations of HOT.Am J Surg Pathol2024
36264673Metastatic prostate cancer diagnosed by fine-needle aspiration: Contemporary cytopathologic and biomarker assessment with clinical correlates.Cancer Cytopathol2023
36250542Characterization of Intercalated Cell Markers KIT and <i>LINC01187</i> in Chromophobe Renal Cell Carcinoma and Other Renal Neoplasms.Int J Surg Pathol2023
36264673Metastatic prostate cancer diagnosed by fine-needle aspiration: Contemporary cytopathologic and biomarker assessment with clinical correlates.Cancer Cytopathol2023
35605606Therapeutic targeting of prenatal pontine ID1 signaling in diffuse midline glioma.Neuro Oncol2023
37605297Discovery of a First-in-Class Degrader for the Lipid Kinase PIKfyve.J Med Chem2023
37851269Clinical, genomic, and epigenomic analyses of H3K27M-mutant diffuse midline glioma long-term survivors reveal a distinct group of tumors with MAPK pathway alterations.Acta Neuropathol2023
37851053Impact of sequencing of androgen receptor-signaling inhibition and radiotherapy in prostate cancer: importance of homologous recombination disruption.World J Urol2023
37597185Distinct mutational processes shape selection of MHC class I and class II mutations across primary and metastatic tumors.Cell Rep2023
37584601Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic Pathways.Cancer Discov2023
38011559Targeting the lipid kinase PIKfyve upregulates surface expression of MHC class I to augment cancer immunotherapy.Proc Natl Acad Sci U S A2023
37904960Clinically relevant humanized mouse models of metastatic prostate cancer to evaluate cancer therapies.bioRxiv2023
37644036Loss of LCMT1 and biased protein phosphatase 2A heterotrimerization drive prostate cancer progression and therapy resistance.Nat Commun2023
37714137Oncogenic Role of THOR, a Conserved Cancer/Testis Long Non-coding RNA.Cell2023
37698493Racial differences in serum chemokines in prostate cancer patients.Cancer2023
37683104Discovery of ARD-1676 as a Highly Potent and Orally Efficacious AR PROTAC Degrader with a Broad Activity against AR Mutants for the Treatment of AR + Human Prostate Cancer.J Med Chem2023
37094128Targeting SWI/SNF ATPases in H3.3K27M diffuse intrinsic pontine gliomas.Proc Natl Acad Sci U S A2023
36585434MyProstateScore in men considering repeat biopsy: validation of a simple testing approach.Prostate Cancer Prostatic Dis2023
37085619Speed reading the epigenome and genome.Nat Biotechnol2023
36828361Highly Recurrent IDH1 Mutations in Prostate Cancer With Psammomatous Calcification.Mod Pathol2023
36581128Characterization of protein S-(2-succino)-cysteine (2SC) succination as a biomarker for fumarate hydratase-deficient renal cell carcinoma.Hum Pathol2023
37267699Genomics driven precision oncology in advanced biliary tract cancer improves survival.Neoplasia2023
36638784Intersection of immune and oncometabolic pathways drives cancer hyperprogression during immunotherapy.Cancer Cell2023
37459541Proxalutamide reduces SARS-CoV-2 infection and associated inflammatory response.Proc Natl Acad Sci U S A2023
36759899Common molecular features of H3K27M DMGs and PFA ependymomas map to hindbrain developmental pathways.Acta Neuropathol Commun2023
37440313LSD1 promotes prostate cancer reprogramming by repressing TP53 signaling independently of its demethylase function.JCI Insight2023
37377606Optimizing Precision Medicine for Breast Cancer Brain Metastases with Functional Drug Response Assessment.Cancer Res Commun2023
37115501Devimistat in Combination with Gemcitabine and Cisplatin in Biliary Tract Cancer: Preclinical Evaluation and Phase Ib Multicenter Clinical Trial (BilT-04).Clin Cancer Res2023
37302711Sex-associated early-life viral innate immune response is transcriptionally associated with chromatin remodeling of type-I IFN-inducible genes.Mucosal Immunol2023
36735698Antisense oligonucleotides to therapeutically target SARS-CoV-2 infection.PLoS One2023
37499055Lessons from 801 clinical TFE3/TFEB fluorescence in situ hybridization assays performed on renal cell carcinoma suspicious for MiTF family aberrations.Am J Clin Pathol2023
37597185Distinct mutational processes shape selection of MHC class I and class II mutations across primary and metastatic tumors.Cell Rep2023
37714137Oncogenic Role of THOR, a Conserved Cancer/Testis Long Non-coding RNA.Cell2023
38011559Targeting the lipid kinase PIKfyve upregulates surface expression of MHC class I to augment cancer immunotherapy.Proc Natl Acad Sci U S A2023
37904960Clinically relevant humanized mouse models of metastatic prostate cancer to evaluate cancer therapies.bioRxiv2023
37851269Clinical, genomic, and epigenomic analyses of H3K27M-mutant diffuse midline glioma long-term survivors reveal a distinct group of tumors with MAPK pathway alterations.Acta Neuropathol2023
37851053Impact of sequencing of androgen receptor-signaling inhibition and radiotherapy in prostate cancer: importance of homologous recombination disruption.World J Urol2023
37584601Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic Pathways.Cancer Discov2023
37698493Racial differences in serum chemokines in prostate cancer patients.Cancer2023
37683104Discovery of ARD-1676 as a Highly Potent and Orally Efficacious AR PROTAC Degrader with a Broad Activity against AR Mutants for the Treatment of AR + Human Prostate Cancer.J Med Chem2023
37644036Loss of LCMT1 and biased protein phosphatase 2A heterotrimerization drive prostate cancer progression and therapy resistance.Nat Commun2023
37499055Lessons from 801 clinical TFE3/TFEB fluorescence in situ hybridization assays performed on renal cell carcinoma suspicious for MiTF family aberrations.Am J Clin Pathol2023
37605297Discovery of a First-in-Class Degrader for the Lipid Kinase PIKfyve.J Med Chem2023
35605606Therapeutic targeting of prenatal pontine ID1 signaling in diffuse midline glioma.Neuro Oncol2023
37459541Proxalutamide reduces SARS-CoV-2 infection and associated inflammatory response.Proc Natl Acad Sci U S A2023
  • 1 - 50 of 1,238

Recommended Authors

Rohan Bareja
Case Western Reserve University
Career Start Year 2017
Number of shared co-authors 48
Vincent Huang
Ontario Institute for Cancer Research
Career Start Year 2016
Number of shared co-authors 22
Ren?? B??ttcher
Universitat Pompeu Fabra
Career Start Year 2012
Number of shared co-authors 9
Julie Livingstone
University of California los angeles
Career Start Year 2011
Number of shared co-authors 54
Matti Annala
University of British Columbia
Career Start Year 2011
Number of shared co-authors 64
Mandeep Takhar
GenomeDx Biosciences Inc.
Career Start Year 2010
Number of shared co-authors 56
Sungyong You
Cedars-Sinai Medical Center
Career Start Year 2008
Number of shared co-authors 32
Siyuan Zheng
Greehey Children's Cancer Research Institute
Career Start Year 2007
Number of shared co-authors 47
Svitlana Tyekucheva
Dana-Farber Cancer Institute
Career Start Year 2006
Number of shared co-authors 19
Matti Nykter
Prostate Cancer Research Center, Tampere University and Tays Cancer Center
Career Start Year 2006
Number of shared co-authors 59
Alok K Tewari
Dana-Farber Cancer Institute, Harvard Medical School
Career Start Year 2005
Number of shared co-authors 16
Charlie E Massie
University of Cambridge
Career Start Year 2003
Number of shared co-authors 19
Daniel S Brewer
University of Washington, USA Institute for Stem Cell and Regenerative Medicine
Career Start Year 2003
Number of shared co-authors 27
Jianhua Zhang
University of Texas MD Anderson Cancer Center
Career Start Year 2003
Number of shared co-authors 33
Jianmin Wang
Roswell Park Comprehensive Cancer Center
Career Start Year 2003
Number of shared co-authors 6
Leslie Cope
Johns Hopkins University School of Medicine
Career Start Year 2003
Number of shared co-authors 33
Obi L Griffith
Washington University
Career Start Year 2003
Number of shared co-authors 31
Joel S Parker
Lineberger Cancer Center, University of North Carolina
Career Start Year 2002
Number of shared co-authors 51
Syed Haider
Institute of Cancer Research
Career Start Year 2002
Number of shared co-authors 31
Luke A Selth
Adelaide Medical School, University of Adelaide
Career Start Year 2002
Number of shared co-authors 26
Tobias Sj??blom
Uppsala University
Career Start Year 1999
Number of shared co-authors 3
Paul T Spellman
Oregon Health & Science University Hospital.
Career Start Year 1998
Number of shared co-authors 34
Ian G Mills
Queen's University Belfast
Career Start Year 1997
Number of shared co-authors 45
Benedikt Brors
German Cancer Research Center (DKFZ)
Career Start Year 1997
Number of shared co-authors 25
Adam B Olshen
12224University of California san francisco
Career Start Year 1993
Number of shared co-authors 22
Holger S??ltmann
German Cancer Research Center (DKFZ)
Career Start Year 1993
Number of shared co-authors 8
Yong-Jie Lu
Barts Cancer Institute, Queen Mary University of London
Career Start Year 1993
Number of shared co-authors 27
Gyorgy Petrovics
Henry Jackson Foundation for the Advancement of Military Medicine (HJF)
Career Start Year 1990
Number of shared co-authors 39
Jonathan R Pollack
Stanford University School of Medicine
Career Start Year 1987
Number of shared co-authors 13
Olli Kallioniemi
Karolinska Institute
Career Start Year 1984
Number of shared co-authors 24

Collaborators

Xuhong Cao
Michigan Center for Translational Pathology.
Co-authored papers 132
Rohit Mehra
Michigan Center for Translational Pathology.
Co-authored papers 125
Scott A Tomlins
Rogel Cancer Center, University of Michigan Medical School ann arbor
Co-authored papers 122
Mark A Rubin
University of Bern
Co-authored papers 102
Javed Siddiqui
Michigan Center for Translational Pathology, University of Michigan ann arbor
Co-authored papers 86
Sooryanarayana Varambally
University of Alabama at Birmingham, USA O'Neal Comprehensive Cancer Center
Co-authored papers 79
Saravana M Dhanasekaran
Co-authored papers 75
Dan R Robinson
Michigan Center for Translational Pathology, University of Michigan ann arbor
Co-authored papers 66
Lakshmi P Kunju
Michigan Center for Translational Pathology, University of Michigan ann arbor
Co-authored papers 60
Chandan Kumar-Sinha
Co-authored papers 57
Robert J Lonigro
Michigan Center for Translational Pathology, University of Michigan ann arbor
Co-authored papers 54
Marcin Cieslik
Co-authored papers 54
Yi-Mi Wu
University of Michigan Medical School ann arbor
Co-authored papers 53
Nallasivam Palanisamy
Vattikuti Urology Institute
Co-authored papers 53
Felix Y Feng
UCSF Medical Center-Mount Zion
Co-authored papers 53
Kenneth J Pienta
The Brady Urological Institute, Johns Hopkins University School of Medicine
Co-authored papers 43
John R Prensner
University of Michigan ann arbor
Co-authored papers 34
Daniel E Spratt
University Hospitals Seidman Cancer Center, Case Western Reserve University
Co-authored papers 33
Pankaj Vats
Michigan Center for Translational Pathology, University of Michigan ann arbor
Co-authored papers 32
Todd M Morgan
University of Michigan ann arbor
Co-authored papers 31
Jianjun Yu
Co-authored papers 25
Francesca Demichelis
University of Trento
Co-authored papers 24
Christopher A Maher
Washington University in St Louis
Co-authored papers 24
Rajen Mody
Co-authored papers 22
Ronglai Shen
Co-authored papers 18
Sriram Venneti
Co-authored papers 18
Johann S de Bono
The Institute for Cancer Research
Co-authored papers 17
Peter S Nelson
Fred Hutchinson Cancer Center
Co-authored papers 17
Ram S Mani
UT Southwestern Medical Center
Co-authored papers 16
Himisha Beltran
Dana-Farber Cancer Institute
Co-authored papers 16
Release 1.2